1.An investigation of clinical features and immunological functions of HCV-specific cytotoxic T lymphocytes in HIV/HCV co-infected patients.
Xiao-fei DU ; Yong-hong ZHANG ; Li-na MA ; Hui-ping YAN ; Xin-yue CHEN ; Hao WU
Chinese Journal of Hepatology 2008;16(5):345-348
OBJECTIVETo investigate the clinical features, CD4+ T and CD8+ T cell counts, HIV RNA load, HCV RNA load, CD8+ T cell responses to HCV of HIV/HCV co-infected and HCV mono-infected patients and to assess the mutual influences of the two viruses in the infection.
METHODSFifty-nine patients with HIV/HCV co-infection were enrolled in this study. Thirty-six patients with HCV mono-infection served as a comparison group. The liver function, peripheral blood CD4+ T and CD8+ T cell counts, HIV RNA load and HCV RNA load were compared between the groups. Peripheral blood mononuclear cells were analyzed by interferon-gamma ELISpot using a panel of HCV antigens.
RESULTSThe frequency of HIV/HCV co-infection in those blood donors in Henan, China was 60.8%. ALT and AST in the HIV/HCV co-infection patients were not different from those of the HCV group. Globulin in the HIV/HCV co-infection group was higher than that in the HCV group (P<0.01). CD4+ T cell counts in the HIV/HCV co-infection group were lower than those in the HCV group, but CD8+ T cell counts in the HIV/HCV co-infection group were higher than those in the HCV group (P<0.01). The HCV RNA loads were higher in the HIV/HCV co-infection group than in the HCV group(P<0.01). The magnitude of HCV-specific CTL response to HCV-NS3 overlapping peptides in the HIV/HCV co-infection group (649.34+/-685.90) was higher than that in the HCV group (1233.70+/-1085.16). Albumin was negatively correlated with HCV RNA (log10copies/ml) in the HIV/HCV co-infection group (r=-0.540). A positive correlation was found between platelet and peripheral blood CD4+ T cell counts (P<0.05). No linear correlation was found between HCV virus loads, HIV virus loads or peripheral blood CD4+ T cell counts.
CONCLUSIONThe frequency of HIV/HCV co-infection in the blood donors in Henan, China was 60.8%. HIV/HCV co-infection aggravated the progress of chronic hepatitis C.
Adult ; CD4 Lymphocyte Count ; Female ; HIV ; HIV Infections ; complications ; diagnosis ; immunology ; virology ; Hepacivirus ; Hepatitis C ; complications ; diagnosis ; immunology ; virology ; Hepatitis C, Chronic ; immunology ; virology ; Humans ; Male ; Middle Aged ; Prognosis ; Superinfection ; diagnosis ; immunology ; T-Lymphocytes, Cytotoxic ; immunology ; Viral Load
2.Effect of GBV-C/HIV coinfection on HIV/AIDS disease progression and HIV replication.
Ting ZHU ; Xin-Ping DING ; Yan-Min WAN ; Lian-Xing LIU ; Hong PENG ; Xiang-Gang HUANG ; Yan-Meng FENG ; Chao WU ; Yu-Hua RUAN ; Li-Feng HAN ; Hui XING ; Jian-Jun WANG ; Bing SU ; Chen XU ; Jian-Qing XU ; Yi-Ming SHAO
Chinese Journal of Virology 2008;24(1):17-21
Several research groups have recently reported that persistent GB virus C (GBV-C) co-infected with human immunodeficiency virus (HIV) leads to slower AIDSs disease progression than HIV-1 infection alone. However, these findings were not confirmed by several other studies. To investigate the association between GBV-C replication and plasma HIV loads and CD4+ T cell counts, 203 HIV-1 positive former blood/plasma donors(FBDs) were enrolled from Fuyang city of Anhui Province in China. Plasma specimens were collected from them and were tested for GBV-C using RT-PCR and ELISA. Out of 203 specimens, 52 (25.6%) cases were positive for GBV-C, including 35 male (67.3%) and 17 female (32.7%) cases. No significant association was identified between GBV-C infection and CD4+ T-cell counts or between GBV-C infection and HIV viral loads. Since all the subjects studied were naive to ART, the influence of therapy on AIDS disease progression was ruled out in this study. Overall, our data indicated that HIV-1 positive male FBDs were prone to be infected, GBV-C coinfection with HIV-1 does not significantly influence HIV/AIDS disease progression during the late stage of chronic HIV-1 infection.
Acquired Immunodeficiency Syndrome
;
complications
;
immunology
;
virology
;
Adult
;
Aged
;
CD4 Lymphocyte Count
;
Disease Progression
;
Female
;
Flaviviridae Infections
;
immunology
;
virology
;
GB virus C
;
HIV-1
;
physiology
;
Hepatitis, Viral, Human
;
immunology
;
virology
;
Humans
;
Male
;
Middle Aged
;
RNA, Viral
;
blood
;
Virus Replication
3.Correlation between HBsAg, HCV expression in cancerous and pericancer tissues of hepatocellular carcinoma and liver fibrosis markers in serum.
Yong-ning XIN ; Shi-ying XUAN ; Guang-jun SHI ; Hua CHEN ; Ying SUN ; Jian ZHANG
Chinese Journal of Hepatology 2005;13(7):513-515
OBJECTIVETo study the correlation between HBsAg and HCV in hepatocellular carcinoma (HCC) pericarcinomatous tissues and serum liver fibrosis markers.
METHODSThe patterns of HBsAg and HCV in 100 cases of HCC and their surrounding liver tissues were studied with paraffin sections using immunohistochemistry techniques. Hyaluronic acid (HA), procollagen III peptide (PIIIP), collagen IV (CIV), and laminin (LN) were detected by radioimmunoassay.
RESULTSThe levels of HA, PIIIP, CIV and LN in the HBV and HCV coinfection group were the highest among the four groups. The levels of HA, PIIIP, CIV and LN in the groups not infected by HBV and HCV were the lowest among the four groups. HBV and HCV expressions were positively correlated with HA, LN and CIV and their Spearman's rank correlation coefficients were 0.60, 0.45, 0.46, respectively (P < 0.01).
CONCLUSIONLiver cancer development follows a sequential trend of chronic hepatitis, liver cirrhosis, and liver cancer. In the tissues of liver cancer with virus infection background, the serum marker level of hepatic fibrosis is obviously higher than those without virus infection background. On the one hand, virus infection is one of the reasons causing liver cancer; and on the other hand, longstanding viremia will aggravate pathological changes of liver tissues. Therefore antivirus treatment of hepatitis is of significance for the prognosis of liver cancer.
Adult ; Aged ; Carcinoma, Hepatocellular ; complications ; virology ; Collagen Type IV ; metabolism ; Female ; Hepacivirus ; immunology ; Hepatitis B Surface Antigens ; metabolism ; Hepatitis B virus ; immunology ; Hepatitis C Antigens ; metabolism ; Humans ; Hyaluronic Acid ; metabolism ; Laminin ; metabolism ; Liver Cirrhosis ; complications ; virology ; Liver Neoplasms ; complications ; virology ; Male ; Middle Aged ; Procollagen ; metabolism
4.Relationship between amount of HBV DNA in serum/liver tissue and hepatitis G virus (HGV) infection in patients with chronic hepatitis B.
Qinghua SHANG ; Jianguo YU ; Hailong ZHUO ; Chuanzhen XU ; Ning WANG ; Guangshu ZHANG
Chinese Journal of Experimental and Clinical Virology 2002;16(4):326-328
OBJECTIVETo observe the relationship between the amount of HBV DNA in serum/liver tissue and HGV infection in patients with chronic hepatitis B (CH-B) for exploring the effect of HGV infection on hepatitis B virus (HBV) replication of CH-B.
METHODSHGV RNA in serum, HGV nonstructural region 5 (NS5) antigen (HGV Ag) in liver tissue and the amount of HBV DNA in serum, liver tissue were detected for 56 patients with CH-B by reverse transcription-polymerase chain reaction (RT-PCR) assay, peroxidase antiperoxidase (PAP) immunohistochemical method and fluorescence quantitative PCR assay, respectively. Then the relationship between HGV Ag expression in liver tissue and HGV RNA expression in serum was analysed and the amount of HBV DNA in serum and liver tissues from the serum HGV RNA or liver tissue HGV Ag positive patients were compared with those of the serum HGV-RNA or liver tissue HGV Ag negative patients, respectively.
RESULTSTen (17.9%) and eight (14.3%) patients were positive for serum and liver tissues,respectively.HGV RNA expression in serum was closely related to HGV Ag expression in liver tissues, but there was HGV RNA in serum from some of the liver tissues HGV Ag negative patients ?cases of HGV RNA and HGV Ag positive or negative,HGV RNA positive but HGV Ag negative, HGV RNA negative but HGV Ag positive, respectively: 5,43,5,3,(P<0.01). There was no significant difference in the amount of HBV DNA in serum and liver tissues between HGV RNA or HGV Ag positive and negative patients (P>0.05).
CONCLUSIONSHGV infection may not affect HBV replication. Liver is the site of HGV replication, but HGV probably also replicates in extrahepatic tissues. HGV hepatic pathogenicity is probably mild and further studies are still needed.
Adult ; DNA, Viral ; analysis ; blood ; Female ; Flaviviridae Infections ; complications ; virology ; GB virus C ; genetics ; immunology ; pathogenicity ; Hepatitis Antigens ; analysis ; Hepatitis B virus ; genetics ; physiology ; Hepatitis B, Chronic ; complications ; virology ; Hepatitis, Viral, Human ; virology ; Humans ; Liver ; virology ; Male ; RNA, Viral ; blood ; Virus Replication
5.The clinical features of hepatitis associated aplastic anemia.
Mei-Feng TU ; Zong-Hong SHAO ; Hong LIU ; Guang-Sheng HE ; Jie BAI ; Jun SHI ; Yan-Ran CAO ; Hua-Quan WANG ; Li-Min XING ; Zhen-Zhu CUI ; Juan SUN ; Hui-Shu CHEN ; Yan-Ping XUE ; Chong-Li YANG
Chinese Journal of Hematology 2005;26(4):239-242
OBJECTIVETo analyse the proportion of hepatitis associated aplastic anemia (HAAA) in severe aplastic anemia (SAA) and its clinical features of HAAA.
METHODSAll newly diagnosed SAA cases in our department in the recent 5 years were analyzed. A case-control study was undertaken to investigate the differences of clinical and laboratory features between HAAA and non-hepatitis associated SAA (non-HASAA) patients.
RESULTSThe proportion of HAAA in SAA was 3.3%. There was no significant difference in PB cell counts, bone marrow hematopoiesis status and the amount of blood transfusion between HAAA and non-HASAA patients. Sera from 13 patients with HAAA were tested for antibodies to hepatitis viruses A, B, and C and hepatitis B surface antigen. Twelve (92.3%) of them had negative serologic results for the tests and only one (7.7%) had a positive result for HBsAg and HBeAg. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were decreased prior to the diagnosis in twelve (92.3%) of the 13 HAAA patients. The percentage of CD4(+) cells in HAAA patients was significantly lower than that in non-HASAA patients (P < 0.05). HAAA patients had higher percentages of CD8(+) cells (P < 0.05) and lower ratios of CD4(+)/CD8(+) (P < 0.05). The early infection rate of the HAAA patients was significantly higher than that of non-HASAA patients (84.6% vs 42.3%, P < 0.05), with different mortalities (61.5% vs 15.4%, P < 0.05). The 2-year survival rate of HAAA patients was significantly lower than that of non-HASAA patients (16.6% vs 83.2%, P < 0.01).
CONCLUSIONThe proportion of HAAA in SAA was 3.3%. Most of HAAA were associated with non-A, non-B and non-C hepatitis virus. Compared with that of non-HASAA, the abnormality of T cell immunity of HAAA was more severe, with a higher frequency of early infection and a higher mortality rate.
Adolescent ; Adult ; Anemia, Aplastic ; blood ; complications ; pathology ; Case-Control Studies ; Female ; Follow-Up Studies ; Hepacivirus ; immunology ; Hepatitis A Antibodies ; blood ; Hepatitis A virus ; immunology ; Hepatitis B Antibodies ; blood ; Hepatitis B virus ; immunology ; Hepatitis C Antibodies ; blood ; Hepatitis, Viral, Human ; blood ; complications ; virology ; Humans ; Male
6.Usefulness of Serum alpha-fetoprotein (AFP) as a Marker for Hepatocellular Carcinoma (HCC) in Hepatitis C Virus Related Cirrhosis: Analysis of the Factors Influencing AFP Elevation without HCC Development.
Kyung Ah KIM ; June Sung LEE ; Eun Sook JUNG ; Jong Yeon KIM ; Won Ki BAE ; Nam Hoon KIM ; Young Soo MOON
The Korean Journal of Gastroenterology 2006;48(5):321-326
BACKGROUND/AIMS: Serum alpha-fetoprotein (AFP) is frequently used for the diagnosis of hepatocellular carcinoma (HCC). Most available data concerning AFP came from studies of patients with chronic hepatitis B or mixed etiologies. Studies concerning the diagnostic value of AFP for HCV-related liver cirrhosis (LC) are limited. We evaluated the factors influencing AFP elevation in the absence of HCC and analyzed the diagnostic value of serum AFP in HCC surveillance of HCV-related LC patients. METHODS: We enrolled 55 patients of HCV-related LC with HCC and 62 patients without HCC as a case-control study were analyzed. The sensitivity and specificity were calculated and the clinical and biochemical factors influencing serum AFP levels. RESULTS: The sensitivities and specificities of serum AFP for the detection of HCC in HCV-related LC were 72.7% and 59.7% for AFP> or =20 ng/mL, and 47.3% and 92.5% for AFP> or =100 ng/mL, respectively. Elevated serum AST was independently associated with elevated serum AFP level in HCV-related LC. In cases of AST< or =2 x upper limit of normal (ULN), the specificity of AFP> or =100 ng/mL for the diagnosis of HCC was 100%. However, in case of AST>2 x ULN, the specificity was 85.0% for AFP> or =100 ng/mL and 95.0% for AFP> or =200 ng/mL. CONCLUSIONS: Serum AST levels influence serum AFP level in HCV-related LC. In cases of AST< or =2 x ULN, AFP greater than 100 ng/mL highly indicates HCC in HCV-related LC, but not in case of AST>2 x ULN.
Aged
;
Carcinoma, Hepatocellular/complications/*diagnosis/pathology
;
Diagnosis, Differential
;
Female
;
Hepatitis C/*complications/immunology/virology
;
Humans
;
Liver Cirrhosis/*virology
;
Liver Neoplasms/complications/*diagnosis/pathology
;
Male
;
Middle Aged
;
Retrospective Studies
;
Sensitivity and Specificity
;
Tumor Markers, Biological/*blood
;
alpha-Fetoproteins/*analysis
7.Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients.
Jae Young JANG ; Soung Won JEONG ; Sung Ran CHEON ; Sae Hwan LEE ; Sang Gyune KIM ; Young Koog CHEON ; Young Seok KIM ; Young Deok CHO ; Hong Soo KIM ; So Young JIN ; Yun Soo KIM ; Boo Sung KIM
The Korean Journal of Hepatology 2011;17(3):206-212
BACKGROUND/AIMS: We investigated the frequency of occult hepatitis B virus (HBV) infection in anti-hepatitis C virus (HCV)-positive individuals and the effects of occult HBV infection on the severity of liver disease. METHODS: Seventy-one hepatitis B virus surface-antigen (HBsAg)-negative patients were divided according to their HBV serological status into groups A (anti-HBc positive, anti-HBs negative; n=18), B (anti-HBc positive, anti-HBs positive; n=34), and C (anti-HBc negative, anti-HBs positive/negative; n=19), and by anti-HCV positivity (anti-HCV positive; n=32 vs. anti-HCV negative; n=39). Liver biopsy samples were taken, and HBV DNA was quantified by real-time PCR. RESULTS: Intrahepatic HBV DNA was detected in 32.4% (23/71) of the entire cohort, and HBV DNA levels were invariably low in the different groups. Occult HBV infection was detected more frequently in the anti-HBc-positive patients. Intrahepatic HBV DNA was detected in 28.1% (9/32) of the anti-HCV-positive and 35.9% (14/39) of the anti-HCV-negative subjects. The HCV genotype did not affect the detection rate of intrahepatic HBV DNA. In anti-HCV-positive cases, occult HBV infection did not affect liver disease severity. CONCLUSIONS: Low levels of intrahepatic HBV DNA were detected frequently in both HBsAg-negative and anti-HCV-positive cases. However, the frequency of occult HBV infection was not affected by the presence of hepatitis C, and occult HBV infection did not have a significant effect on the disease severity of hepatitis C.
Adult
;
Aged
;
Cohort Studies
;
DNA, Viral/analysis
;
Female
;
Genotype
;
Hepatitis B/*complications/*diagnosis
;
Hepatitis B Core Antigens/blood/immunology
;
Hepatitis B Surface Antigens/blood/immunology
;
Hepatitis B virus/*genetics
;
Hepatitis C, Chronic/*complications/genetics/*pathology
;
Humans
;
Liver/virology
;
Male
;
Middle Aged
;
Polymerase Chain Reaction
;
Severity of Illness Index
8.Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients.
Jeong Hwan YOO ; Seong Gyu HWANG ; Dong Ho YANG ; Myung Su SON ; Chang Il KWON ; Kwang Hyun KO ; Sung Pyo HONG ; Pil Won PARK ; Kyu Sung RIM
The Korean Journal of Gastroenterology 2013;61(4):209-214
BACKGROUND/AIMS: The prevalence of occult HBV infection depends on the prevalence of HBV infection in the general population. Hemodialysis patients are at increased risk for HBV infection. The aim of this study was to determine the prevalence of occult HBV infection in hemodialysis patients. METHODS: Total of 98 patients undergoing hemodialysis in CHA Bundang Medical Center (Seongnam, Korea) were included. Liver function tests and analysis of HBsAg, anti-HBs, anti-HBc and anti-HCV were performed. HBV DNA testing was conducted by using two specific quantitative methods. RESULTS: HBsAg was detected in 4 of 98 patients (4.1%), and they were excluded. Among 94 patients with HBsAg negative and anti-HCV negative, one (1.1%) patient with the TaqMan PCR test and 3 (3.2%) patients with the COBAS Amplicor HBV test were positive for HBV DNA. One patient was positive in both methods. Two patients were positive for both anti-HBs and anti-HBc and one patient was negative for both anti-HBs and anti-HBc. CONCLUSIONS: The present study showed the prevalence of occult HBV infection in HBsAg negative and anti-HCV negative patients on hemodialysis at our center was 3.2%. Because there is possibility of HBV transmission in HBsAg negative patients on hemodialysis, more attention should be given to prevent HBV transmission.
Adult
;
Aged
;
Aged, 80 and over
;
Antibodies/blood
;
DNA, Viral/analysis
;
Feces/*virology
;
Female
;
Hepatitis B/complications/*epidemiology/transmission
;
Hepatitis B Core Antigens/immunology
;
Hepatitis B virus/genetics/immunology
;
Hepatitis C Antibodies/blood
;
Humans
;
Kidney Failure, Chronic/*complications/diagnosis
;
Male
;
Middle Aged
;
Polymerase Chain Reaction
;
Prevalence
;
Renal Dialysis
;
Risk Factors
9.Investigation on the influence of alcohol on chronic hepatitis C patients.
Jian CHEN ; Min WANG ; Yan-qing LI ; Xing-jie SHEN ; Wei-dong ZHAO
Chinese Journal of Hepatology 2003;11(10):624-625
Adult
;
Aged
;
Alcohol Drinking
;
adverse effects
;
Alcoholism
;
complications
;
Hepacivirus
;
physiology
;
Hepatitis C, Chronic
;
pathology
;
virology
;
Humans
;
Interferon-alpha
;
adverse effects
;
therapeutic use
;
Liver
;
immunology
;
pathology
;
Liver Cirrhosis
;
etiology
;
pathology
;
Male
;
Middle Aged
;
RNA, Viral
;
biosynthesis
;
Virus Replication
;
drug effects
10.Meta-analysis on peginterferon plus ribavirin in treatment of hepatitis C virus genotype 1 or 4 infection in HIV patients.
Si-Hai ZHAO ; En-Qi LIU ; Da-Xin CHENG ; Xin XUE ; Yong-Lie CHU
Journal of Zhejiang University. Medical sciences 2009;38(3):315-319
OBJECTIVETo perform a Meta-analysis on peginterferon with interferon in treatment of HIV patients coinfected with refractory genotype HCV.
METHODSA literature search of Medline was conducted to identify eligible randomized controlled trials. Meta analysis was conducted to evaluate peginterferon and interferon in treatment of coinfected HCV genotype 1 or 4 in HIV patients.
RESULTSix trials of 88 matched the selection criteria. Total 1,131 patients with coinfection of HCV genotype 1 or 4 and HIV were included. Sustain viral response was higher in patients treated with peginterferon plus ribavirin compared with that of interferon plus ribavirin (26 % compared with 8 %) or peginterferon alone (26 % compared with 13 %). Severe adverse effects and withdrawal rates were similar for patients treated with peginterferon and patients treated with interferon.
CONCLUSIONPeginterferon plus ribavirin in treatment of patients with coinfection of genotype 1 or 4 HCV and HIV can achieve higher sustain viral response and the likelihoods of serious adverse effects and withdrawal rates are similar to other therapies.
Adult ; Antiviral Agents ; administration & dosage ; Drug Therapy, Combination ; Female ; Genotype ; HIV Infections ; complications ; drug therapy ; immunology ; Hepacivirus ; classification ; genetics ; Hepatitis C, Chronic ; complications ; drug therapy ; virology ; Humans ; Interferon-alpha ; administration & dosage ; Male ; Polyethylene Glycols ; administration & dosage ; Randomized Controlled Trials as Topic ; Recombinant Proteins ; Ribavirin ; administration & dosage